Utility of C2 Monitoring in Prediction of Diastolic Dysfunction in Renal Transplant Recipients

Transplantation Proceedings

Volumn 40, Issue 1, 2008, Pages 171-173

  Kirkpantur, A ^a   Yilmaz, R ^a   Abali, G ^a   Arici, M ^a   Altun, B ^a   Aki, T ^a   Erkan, I ^a   Bakkaloglu, M ^a   Yasavul, U ^a   Turgan, C ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC DYSFUNCTION; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; KIDNEY GRAFT; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; CYCLOSPORINE; DIASTOLE; DRUG MONITORING; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC;

EID: 38749123993     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.11.031     Document Type: Article

References (13)

1. Pescovitz M.D., Barbeito R., and Simulect US01 Study Group. Two-hour post-dose cyclosporine level is a better predictor than trough level of acute rejection of renal allografts. Clin Transpl 16 (2002) 378
2. Levy G., Thervet E., Lake J., et al. Patient management by Neoral C2 monitoring: an international consensus. Transplantation 73 (2002) S12
3. Keown P.A. New concepts in cyclosporine monitoring. Curr Opin Nephrol Hypertens 11 (2002) 619
4. Sahn D.J., De Maria A., Kisslo J., et al. Recommendations regarding quantitation in M-mode echocardiographic measurements. Circulation 58 (1978) 1072
5. Bianchi R., Rodella L., and Rezzani R. Cyclosporine A upregulates expression of matrix matalloproteinase 2 and vascular endothelial growth factor in rat heart. Int Immunopharmacol 3 (2003) 427
6. Rezzani R., Rodella L., Dessy C., et al. Changes in Hsp90 expression determine the effects of cyclosporine A on the NO pathway in rat myocardium. FEBS Lett 552 (2003) 125
7. Laczkovics A., Havel M., Teufelsbauer H., et al. Cyclosporin-A induced heart failure after orthotopic heart transplantation. J Thorac Cardiovasc Surg 35 (1987) 83
8. Siostrzonek P., Teufelsbauer H., Kreiner G., et al. Relief of diastolic cardiac dysfunction after cyclosporine withdrawal in a cardiac transplant recipient. Eur Heart J 14 (1993) 859
9. Rezzani R., Giugno L., Buffoli B., et al. The protective effect of caffeic acid phenethyl ester against cyclosporine A-induced cardiotoxicity in rats. Toxicology 212 (2005) 155
10. Spinale F.G. Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circ Res 90 (2002) 520
11. Siwik D.A., Pagano P.J., and Colucci W.S. Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. Am J Physiol Cell Physiol 280 (2001) C35
12. Weber K.T. Cardiac interstitium in health and disease: the fibrillar collagen network. J Am Coll Cardiol 13 (1989) 1637
13. Capasso J.M., Palackal T., Olivetti G., et al. Left ventricular failure induced by long-term hypertension in rats. Circ Res 66 (1990) 1400